The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

  1. Lin, L.
  2. Sabnis, A.J.
  3. Chan, E.
  4. Olivas, V.
  5. Cade, L.
  6. Pazarentzos, E.
  7. Asthana, S.
  8. Neel, D.
  9. Yan, J.J.
  10. Lu, X.
  11. Pham, L.
  12. Wang, M.M.
  13. Karachaliou, N.
  14. Cao, M.G.
  15. Manzano, J.L.
  16. Ramirez, J.L.
  17. Torres, J.M.S.
  18. Buttitta, F.
  19. Rudin, C.M.
  20. Collisson, E.A.
  21. Algazi, A.
  22. Robinson, E.
  23. Osman, I.
  24. Muñoz-Couselo, E.
  25. Cortes, J.
  26. Frederick, D.T.
  27. Cooper, Z.A.
  28. Mcmahon, M.
  29. Marchetti, A.
  30. Rosell, R.
  31. Flaherty, K.T.
  32. Wargo, J.A.
  33. Bivona, T.G.
  34. Erakutsi egile guztiak +
Aldizkaria:
Nature Genetics

ISSN: 1546-1718 1061-4036

Argitalpen urtea: 2015

Alea: 47

Zenbakia: 3

Orrialdeak: 250-256

Mota: Artikulua

DOI: 10.1038/NG.3218 GOOGLE SCHOLAR